Evidence map›Paper›PMID 27043027›Full record

ArticleRheumatology international2017

Erratum to: Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival.

Andreu Fernández-Codina, Carmen Pilar Simeón-Aznar, Iago Pinal-Fernandez, José Rodríguez-Palomares, Maria Nazarena Pizzi, Cristina Eve Hidalgo, Alfredo Guillén-Del Castillo, Francisco Javier Prado-Galbarro, Antonio Sarria-Santamera, Vicent Fonollosa-Plà and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pulmonary hypertension phenotypes in patients with systemic sclerosis.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Andreu Fernández-CodinaDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. andreu.fernandez@vhebron.net.
Carmen Pilar Simeón-AznarDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Iago Pinal-FernandezDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
José Rodríguez-PalomaresCardiology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Maria Nazarena PizziNuclear Medicine Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Cristina Eve HidalgoDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Alfredo Guillén-Del CastilloDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Francisco Javier Prado-GalbarroAgencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, Madrid, Spain.
Antonio Sarria-SantameraAgencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud Carlos III, Madrid, Spain.
Vicent Fonollosa-PlàDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Miquel Vilardell-TarrésDepartment of Internal Medicine, Systemic Autoimmune Diseases Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 3rd floot, Hospital General Vall d'Hebron building, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.